coagulation factor VII
Ultimo aggiornamento 18 Ago 2020
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
L F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Scelte video per GenesVideo library
Normal function
L F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Coagulation factor VII is made primarily by cells in the liver. The protein circulates in the bloodstream in an inactive form until the coagulation system is turned on (activated) by an injury that damages blood vessels. Activated coagulation factor VII helps turn on other coagulation factors in turn. This step-wise process ultimately promotes the conversion of an important coagulation protein called fibrinogen into fibrin, which is the material that forms blood clots.
Conditions referring to this gene or chromosome
Altri nomi
FVII coagulation protein
proconvertin
serum prothrombin conversion accelerator
SPCA
Related patient information and medicines

Patient information leaflet
Trombofilia
It can lead to venous blood clots, often in unusual sites such as the veins of the gut, liver or... Anticoagulation may be needed and there are other treatments too for this condition. Elevated factor VIII This is pronounced 'factor 8'. It is due to abnormally high levels of factor VIII, which is one of the blood chemicals that promotes clotting..

Patient information leaflet
Test di coagulazione del sangue
Test di coagulazione del sangue are used to diagnose e assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. One or more of these tests may be done if a gene... For example, the amount of factor VIII can be measured in a blood sample. (The level is very low or absent in people with haemophilia A.) Platelet.

Patient information leaflet
Emofilia
Emofilia è a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding... A newer treatment has been developed that does not directly replace the clotting factor. It is a monoclonal antibody.

Patient information leaflet
Esofago di Barrett
Barrett'. It typically affects people between the ages of 50 and 70 years. The coil then emits heat ene... Nearby normal cells then multiply and replace the destroyed abnormal cells. Coagulazione al plasma di argon This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR).

Patient information leaflet
Pre-eclampsia
Complications Most women with pre-eclampsia or HE... The risk of complications increases the more severe the pre-eclampsia becomes. The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare ma serious complication è disseminated intravascular coagulation, which can occur if a woman has had to have many blood.

Patient information leaflet
Emorroidi
The piles then die and drop off, similar to after banding. Coagulazione/ fotocoagulazione a infrarossi This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding treatment and injection sclerotherapy for first- and second-degree piles..
Ulteriori letture e riferimenti
- coagulation factor VII; MedlinePlus, National Library of Medicine.
- Girolami A, Cosi E, Santarossa C, Ferrari S, Luigia Randi M. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII. Semin Thromb Hemost. 2015 Jun;41(4):366-73. doi: 10.1055/s-0035-1549851. Epub 2015 May 14.
- Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30.
- Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost. 2009 Jun;35(4):400-6. doi: 10.1055/s-0029-1225762. Epub 2009 Jul 13.
- Mariani G, Herrmann FH, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7). Blood. 2000 Jul 1;96(1):374. No abstract available.
- Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F; International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005 Mar;93(3):481-7. doi: 10.1160/TH04-10-0650.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

